A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia

Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study

(2021) Mario Tumbarello et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors

(2021) Milo Gatti et al.   Expert Review of Clinical Pharmacology

Continuous Infusion, Therapeutic Drug Monitoring and Outpatient Parenteral Antimicrobial Therapy with Ceftazidime-Avibactam: a Retrospective Cohort Study.

(2021) Véronique Goncette et al.   Journal of Global Antimicrobial Resistance

Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections

(2021) Milo Gatti et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review

(2021) Alex Soriano et al.   Infectious Diseases and Therapy

Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections

(2021) Milo Gatti et al.   Antibiotics-Basel

Augmented Renal Clearance

(2019) Aaron M. Cook et al.   PHARMACOTHERAPY

Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections

(2018) Ryan K. Shields et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials

(2018) Konstantinos Z Vardakas et al.   LANCET INFECTIOUS DISEASES

Renal Dosing of Antibiotics: Are We Jumping the Gun?

(2018) Ryan L Crass et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetics and Pharmacodynamics of β-Lactamase Inhibitors

(2018) Ryan L. Crass et al.   PHARMACOTHERAPY

Antimicrobial Resistance

(2016) Hilary D. Marston et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Avibactam Alone and in Combination with Ceftazidime in Healthy Male Volunteers: Results of Two Randomized, Placebo-Controlled Studies

(2015) Henri Merdjan et al.   CLINICAL DRUG INVESTIGATION

Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens

(2015) David P. Nicolau et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Determination of avibactam and ceftazidime in human plasma samples by LC–MS

(2015) Henrik Sillén et al.   Bioanalysis